MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations

    F. Akcimen (Bethesda, USA)

  • Laryngeal Dystonia, Dopa-Responsive Parkinsonism and Primary Progressive Aphasia with Alzheimer Disease Pathology

    A. Eid, R. Perrin, J. Perlmutter, S. Norris (Saint Louis, USA)

  • LED Light as an Inductor of Optogenetic Activation of Astrocytes in Multiple System Atrophy

    F. Kiryukhin, D. Labunskiy, S. Kiryukhina, O. Zheleznikova (Moscow, Russian Federation)

  • Leveraging a Smartphone-based Platform for Parkinson’s disease Real-world Research: A Multicenter, Cross-sectional Feasibility Assessment Study

    Z. Xu, Y. Tang, J. Wang (Shanghai, China)

  • Leveraging Duty-cycle Based Programming for Deep Brain Stimulation

    P. Zeilman, R. Burke, P. Graese, J. Wong (Gainesville, USA)

  • Levodopa and DBS Produce Discordant Effects on Parkinsonian Features

    T. Lee, D. Ramesh, J. Perlmutter, J. Younce (Chapel Hill, USA)

  • Levodopa Effects In Swedd: Clinical And Kinematic Insights From A Case Report

    D. Birreci, L. Angelini, A. Martini, S. Grandolfo, M. de Riggi, S. Aloisio, M. Bologna (Rome, Italy)

  • Levodopa mediated normalization of cerebello-thalamo-cortical GABA and Glutamate in Parkinson’s disease

    S. Prasad, D. Deelchand, M. Kumar, R. Yadav, P. Pal, J. Saini (Bengaluru, India)

  • Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy

    V. Arca, J. Jurkeviciene, S. Wrigley, P. Cullinane, J. Parmera, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

  • Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner

    E. Luna, K. Cousins, S. Emrani, K. Luk, V. Lee, E. Lee, D. Weintraub, S. Xie, A. Chen-Plotkin, F. Bennett, D. Irwin (Philadelphia, USA)

  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • An atypical and interesting feature of Parkinson´s disease
  • #25116 (not found)
  • #28409 (loading title)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley